DK0488928T3 - Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc - Google Patents

Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc

Info

Publication number
DK0488928T3
DK0488928T3 DK91500137T DK91500137T DK0488928T3 DK 0488928 T3 DK0488928 T3 DK 0488928T3 DK 91500137 T DK91500137 T DK 91500137T DK 91500137 T DK91500137 T DK 91500137T DK 0488928 T3 DK0488928 T3 DK 0488928T3
Authority
DK
Denmark
Prior art keywords
mixture
pharmaceutical formulations
hyperc
treatment
formulations
Prior art date
Application number
DK91500137T
Other languages
English (en)
Inventor
Granja Abilio Laguna
Lezcano Ruben Pablo Ramos
Hernandez Evangelina Urribari
Naranjo Urbano Gregori Perdomo
Fernsndez Daysi Carvajal
Rojas Jose Manuel Martinez
Otero Margarita Juana Lorenzo
Loret De Mola Liliana Montejo
Ferreiro Rosa Mas
Hernandez Juan Magraner
Maria De Lourdes Arruzazabala
Original Assignee
Cent Nac Investig Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cent Nac Investig Scient filed Critical Cent Nac Investig Scient
Application granted granted Critical
Publication of DK0488928T3 publication Critical patent/DK0488928T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91500137T 1990-11-30 1991-11-29 Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc DK0488928T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU90185A CU22225A1 (es) 1990-11-30 1990-11-30 Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos

Publications (1)

Publication Number Publication Date
DK0488928T3 true DK0488928T3 (da) 2000-03-20

Family

ID=5459509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91500137T DK0488928T3 (da) 1990-11-30 1991-11-29 Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc

Country Status (11)

Country Link
EP (1) EP0488928B1 (da)
JP (1) JP2664111B2 (da)
AT (1) ATE183648T1 (da)
BR (1) BR9105185A (da)
CA (1) CA2056657A1 (da)
CU (1) CU22225A1 (da)
DE (2) DE69131553T2 (da)
DK (1) DK0488928T3 (da)
ES (1) ES2137927T3 (da)
GR (1) GR3031957T3 (da)
MX (1) MX9102268A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
FR2693876A1 (fr) * 1992-07-24 1994-01-28 Vani Complément nutritif à base de micronutriments.
CU22723A1 (es) * 1997-04-02 2002-02-28 Dalmer Lab Sa Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
ES2342449T3 (es) 1998-10-09 2010-07-06 Mitsui Sugar Co., Ltd. Profilacticos/medicamentos para la infeccion, agentes anti-endotoxinas, adyuvantes de vacunas y estimuladores del crecimiento.
US6596776B2 (en) 1999-06-21 2003-07-22 Hauser, Inc. High molecular weight primary aliphatic alcohols obtained from natural products and uses thereof
US6225354B1 (en) * 1999-06-21 2001-05-01 Cholesterol Control Laboratories, Inc. High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
JP5555894B2 (ja) * 2005-03-10 2014-07-23 日油株式会社 脂質代謝調整剤
JP2007091672A (ja) * 2005-09-29 2007-04-12 Nof Corp アディポネクチン上昇剤
EP2398476B1 (en) * 2009-02-23 2018-02-07 Nanorx, Inc. Policosanol nanoparticles
CN113057941B (zh) * 2021-03-26 2022-06-17 中国林业科学研究院资源昆虫研究所 一种改善学习记忆的高级烷醇脂质体及其制备方法
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61263937A (ja) * 1985-05-17 1986-11-21 Taiyo Kagaku Kk オクタコサノ−ル含有水性組成物
JPS6289637A (ja) * 1985-05-31 1987-04-24 Seitetsu Kagaku Co Ltd 直鎖第１級脂肪族高級アルコ−ルの抽出法
JPS6299323A (ja) * 1985-10-25 1987-05-08 Yoshihide Hagiwara 高脂血症剤

Also Published As

Publication number Publication date
JPH06192072A (ja) 1994-07-12
EP0488928B1 (en) 1999-08-25
DE488928T1 (de) 1993-11-25
EP0488928A2 (en) 1992-06-03
GR3031957T3 (en) 2000-03-31
ES2137927T3 (es) 2000-01-01
CU22225A1 (es) 1995-01-31
DE69131553T2 (de) 2000-05-04
DE69131553D1 (de) 1999-09-30
BR9105185A (pt) 1992-06-23
EP0488928A3 (en) 1992-11-19
CA2056657A1 (en) 1992-05-31
ATE183648T1 (de) 1999-09-15
JP2664111B2 (ja) 1997-10-15
MX9102268A (es) 1992-10-30

Similar Documents

Publication Publication Date Title
BG104560A (en) Long active injectable formulations containing hydrogenated castor oil
SE7903186L (sv) Cerebralverksamt medel
DK0867179T3 (da) Sammensætning af L-DOPA-estere
DK267689D0 (da) Ikke-beta-oxiderbare fede syrer analoge med blodcholesterol- og -triglyceridsaenkende evne og praeparater indeholdende saadanne forbindelser
DK0488928T3 (da) Pharmaceutiske formuleringer, der indeholder en blanding af højere, primære, alifatiske alkoholer, til behandling af hyperc
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
MX9204881A (es) Composicion farmaceutica que comprende moleculas activas, receptoras de calcio.
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
DE3865102D1 (de) Lipide regulierende zusammensetzungen.
AU631738B2 (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
MX9300204A (es) Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide.
ATE121405T1 (de) Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
FI923662A0 (fi) Terapeutiska medel.
DE69018099D1 (de) Polyamin-Derivate als antineoplastische Mittel.
ATE18761T1 (de) Carbamoyloxybenzhydrol-derivate, ihre herstellung und ihre pharmazeutische zusammensetzungen.
ATE131729T1 (de) 3,5-diiod-l-thyronin zur tsh-suppression und behandlung von struma
KR880013562A (ko) 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물
FR2648135B1 (fr) Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique
KR930017580A (ko) 혈액 순환의 중단후 근육 손상을 치료하기 위한 키산틴 유도체의 용도
SE8204791L (sv) Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar